ProCE Banner Activity

Patient Resource: Postsurgery Treatment Options for HER2-Negative Early-Stage Breast Cancer

PDF

Download this resource to help with shared decision-making related to adjuvant therapy for patients with HER2-negative early-stage breast cancer.

Released: September 17, 2024

Expiration: September 16, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Breastcancer.org

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner